vs
Side-by-side financial comparison of BillionToOne, Inc. (BLLN) and RING ENERGY, INC. (REI). Click either name above to swap in a different company.
BillionToOne, Inc. is the larger business by last-quarter revenue ($83.5M vs $66.9M, roughly 1.2× RING ENERGY, INC.). On growth, BillionToOne, Inc. posted the faster year-over-year revenue change (117.4% vs -19.8%).
BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.
Siemens Energy AG is a German publicly traded energy corporation formed through the spin-off of the former Gas and Power division of Siemens, and it includes full ownership of Siemens Gamesa.
BLLN vs REI — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $83.5M | $66.9M |
| Net Profit | $5.7M | — |
| Gross Margin | 69.9% | — |
| Operating Margin | 11.5% | -37.6% |
| Net Margin | 6.8% | — |
| Revenue YoY | 117.4% | -19.8% |
| Net Profit YoY | 138.3% | — |
| EPS (diluted) | $0.10 | $-0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $66.9M | ||
| Q3 25 | $83.5M | $78.6M | ||
| Q2 25 | — | $82.6M | ||
| Q1 25 | — | $79.1M | ||
| Q4 24 | $45.1M | $83.4M | ||
| Q3 24 | $38.4M | $89.2M | ||
| Q2 24 | — | $99.1M | ||
| Q1 24 | — | $94.5M |
| Q4 25 | — | — | ||
| Q3 25 | $5.7M | $-51.6M | ||
| Q2 25 | — | $20.6M | ||
| Q1 25 | — | $9.1M | ||
| Q4 24 | $-11.5M | — | ||
| Q3 24 | $-14.9M | $33.9M | ||
| Q2 24 | — | $22.4M | ||
| Q1 24 | — | $5.5M |
| Q4 25 | — | — | ||
| Q3 25 | 69.9% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 57.1% | — | ||
| Q3 24 | 52.6% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | -37.6% | ||
| Q3 25 | 11.5% | -70.0% | ||
| Q2 25 | — | 28.4% | ||
| Q1 25 | — | 28.3% | ||
| Q4 24 | 17.0% | 28.3% | ||
| Q3 24 | -32.9% | 33.4% | ||
| Q2 24 | — | 42.2% | ||
| Q1 24 | — | 39.8% |
| Q4 25 | — | — | ||
| Q3 25 | 6.8% | -65.7% | ||
| Q2 25 | — | 25.0% | ||
| Q1 25 | — | 11.5% | ||
| Q4 24 | -25.5% | — | ||
| Q3 24 | -38.8% | 38.0% | ||
| Q2 24 | — | 22.6% | ||
| Q1 24 | — | 5.8% |
| Q4 25 | — | $-0.07 | ||
| Q3 25 | $0.10 | $-0.25 | ||
| Q2 25 | — | $0.10 | ||
| Q1 25 | — | $0.05 | ||
| Q4 24 | $-1.13 | $0.03 | ||
| Q3 24 | $-1.47 | $0.17 | ||
| Q2 24 | — | $0.11 | ||
| Q1 24 | — | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $195.2M | $902.9K |
| Total DebtLower is stronger | $55.0M | — |
| Stockholders' EquityBook value | $-239.5M | $836.3M |
| Total Assets | $327.5M | $1.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $902.9K | ||
| Q3 25 | $195.2M | $286.9K | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $1.1M | ||
| Q4 24 | $191.5M | $1.9M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $1.2M | ||
| Q1 24 | — | $1.4M |
| Q4 25 | — | — | ||
| Q3 25 | $55.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $51.5M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $836.3M | ||
| Q3 25 | $-239.5M | $847.7M | ||
| Q2 25 | — | $897.9M | ||
| Q1 25 | — | $876.0M | ||
| Q4 24 | $-251.7M | $858.6M | ||
| Q3 24 | $-242.9M | $851.3M | ||
| Q2 24 | — | $817.4M | ||
| Q1 24 | — | $793.0M |
| Q4 25 | — | $1.4B | ||
| Q3 25 | $327.5M | $1.4B | ||
| Q2 25 | — | $1.5B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | $302.1M | $1.4B | ||
| Q3 24 | — | $1.4B | ||
| Q2 24 | — | $1.4B | ||
| Q1 24 | — | $1.4B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $13.8M | $44.7M |
| Free Cash FlowOCF − Capex | $6.5M | — |
| FCF MarginFCF / Revenue | 7.7% | — |
| Capex IntensityCapex / Revenue | 8.8% | — |
| Cash ConversionOCF / Net Profit | 2.42× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $44.7M | ||
| Q3 25 | $13.8M | $44.5M | ||
| Q2 25 | — | $33.3M | ||
| Q1 25 | — | $28.4M | ||
| Q4 24 | — | $47.3M | ||
| Q3 24 | — | $51.3M | ||
| Q2 24 | — | $50.6M | ||
| Q1 24 | — | $45.2M |
| Q4 25 | — | — | ||
| Q3 25 | $6.5M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 7.7% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 8.8% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 2.42× | — | ||
| Q2 25 | — | 1.61× | ||
| Q1 25 | — | 3.11× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.52× | ||
| Q2 24 | — | 2.26× | ||
| Q1 24 | — | 8.19× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
REI
Segment breakdown not available.
